2026-07-22 00:00 China Clinical Recruitment & Enrollment Translated from EN

NeuroXess Registers Fully Implanted Wireless Functional BCI Study for Upper-Limb Functional Replacement

Summary NeuroXess registered a prospective, multicenter, single-arm trial (NCT07720882) enrolling people with tetraplegia caused by spinal cord injury to evaluate the safety and clinical efficacy of an implantable BCI system for compensatory hand movement and upper-limb functional replacement. The study is at the registration stage with no results yet.

Why it matters Registering a fully implanted, wireless BCI under an NCT number makes NeuroXess's upper-limb replacement data publicly trackable and adds a reference point to the clinical-evidence base for domestic invasive BCIs.

NeuroXess Technology (shanghai) Co.,Ltd. registered a prospective, multicenter, single-arm clinical trial (registration NCT07720882) enrolling subjects with tetraplegia secondary to spinal cord injury, using an implantable brain-computer interface system to reconstruct upper-limb function.

The trial aims to evaluate the safety and clinical efficacy of the implantable BCI system for compensatory hand motor function in achieving upper-limb functional replacement.

Compiled by BCIwiki from public sources

Sources · 1

clinicaltrials.gov 2026-07-22

Huashan Hospital NeuroXess Wireless Implants Motor Decoding China

From these organizations

2026-09 Huashan Hospital OPM-MEG Beats EEG by 3.6 Points in Non-Invasive Speech Decoding 2026-08 NeuroXess BCI Plans Across 10 Chinese Provinces All Target 2030, Only Zhejiang and Beijing Reimburse 2026-07 NeuroXess NeuroXess 'Sanquan' BCI Enters CMDE Innovative Medical Device Review Program 2026-06 NeuroXess NeuroXess Says Two Paralyzed Patients Played Brain-Controlled Chess 800 km Apart

Huashan Hospital → NeuroXess →

Read original ↗

Suggest a correction Revisions · none 中 / EN